CN104569206B - A kind of measure blood plasma middle reaches ionization compound concentration, logD and the method for compound protein combination rate - Google Patents

A kind of measure blood plasma middle reaches ionization compound concentration, logD and the method for compound protein combination rate Download PDF

Info

Publication number
CN104569206B
CN104569206B CN201510017619.8A CN201510017619A CN104569206B CN 104569206 B CN104569206 B CN 104569206B CN 201510017619 A CN201510017619 A CN 201510017619A CN 104569206 B CN104569206 B CN 104569206B
Authority
CN
China
Prior art keywords
compound
concentration
hollow
blood plasma
fibre membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510017619.8A
Other languages
Chinese (zh)
Other versions
CN104569206A (en
Inventor
李优鑫
包建民
宝贵荣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin University
Original Assignee
Tianjin University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin University filed Critical Tianjin University
Priority to CN201510017619.8A priority Critical patent/CN104569206B/en
Publication of CN104569206A publication Critical patent/CN104569206A/en
Application granted granted Critical
Publication of CN104569206B publication Critical patent/CN104569206B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses and a kind of measure blood plasma middle reaches ionization compound concentration, log D and the method for compound protein combination rate, measure blood plasma middle reaches ionization compound concentration and the method for log D, step: (1), hatches containing compound and the donor phase of blood plasma with phosphate buffer solution preparation;(2) n-octyl alcohol is injected in hollow-fibre membrane;Adding phosphate buffer solution in bag filter, hollow-fibre membrane and bag filter are put in the solution that step (1) obtains, extraction makes balance;(3) take out liquid in bag filter, analyze the concentration [D] of compound in buffer solution with HPLCd, this concentration is equivalent to ionization compound concentration in blood plasma middle reaches during balance;Take out liquid in hollow-fibre membrane, compound concentration [D] in n-octyl alcohol when analyzing balance with HPLCa, calculate the log D of compound in blood plasma;It is few that the present invention analyzes speed biological sample amount fast, that need, sensitive, easy and simple to handle, low cost, need not the instrument of costliness, environmental protection.

Description

A kind of measure blood plasma middle reaches ionization compound concentration, log D and the method for compound protein combination rate
Technical field
The present invention relates to a kind of blood plasma middle reaches ionization compound concentration of mensuration simultaneously, log D and the method for compound protein combination rate.
Technical background
Along with developing rapidly, for the screening of compound of the subjects such as human activities environment, protein science, combinatorial chemistry, computer Provide thousands of new model, novel targets, new technique, promote the high development of screening compound research.Screening compound Be from synthesis or natural product compound to possibly as candidate compound carry out preliminary Pharmacological Activity Screening process.Chemical combination In thing screening, need substantial amounts of candidate compound to be carried out analysis of physical and chemical property, such as dissolubility, infiltration coefficient, compound protein Combination rate, log D and the mensuration of log P.Wherein the lipotropy of compound is an important physicochemical property of compound, it with Compound absorption in vivo, distribution, metabolism, excretion, toxicological profile, even with blood brain barrier permeability and compound Removing have important relation.The Determination of oil-water partition coefficient of compound is often used as the lipophilic parameter of characterization compound, and it is fixed Justice is the logarithm of compound partition coefficient between n-octyl alcohol and water, i.e. log D.
At present, the method measuring compound Determination of oil-water partition coefficient is a lot, including fask oscillating method, chromatography, pH value measure, fixes Changing synthetic membrane and dialysis tube method, wherein, classical way is fask oscillating method, and common method is chromatography.Fask oscillating method is the simplest and normal Method, but need to consume substantial amounts of organic reagent in mensuration, be unfavorable for environmental protection, and this method is bothersome, laborious, Sample is asked to have higher purity and good stability.It addition, in experiment shakes procedure, organic facies and aqueous phase are easily generated Emulsion, causes the biphase result thoroughly not occurring mistake when separating.Measure the chromatography of Determination of oil-water partition coefficient, including Thin layer chromatography, reversed phase high performance liquid phase method, hydrophilic compound-formation chromatography, counter current chromatography and microemulsion electrokinetic chromatography.Chromatography It it is the relational model of chromatographic system based on the compound setting up a series of known Determination of oil-water partition coefficient experiment value.Being total to of these methods It is that these assay methods can have similar functional groups or belong to the profit distribution of isonomic compound by Accurate Determining with feature Coefficient.But, when not having the identical compound of structure, the result that the method obtains is the most inaccurate.
The seminar of Bao Jianmin professor in 2006 proposes hollow fiber membrane liquid-phase micro extraction method and measures the profit distribution of compound Coefficient (Guo Y G, Zhang J, Liu D N, Fu H F.Determination of n-octanol-water partition coefficients by hollow-fiber membrane solvent microextraction coupled with HPLC,Anal.Bioanalytical Chem. 386 (7-8), 2193-2198 (2006) .), the method can directly measure the Determination of oil-water partition coefficient of compound.
Meanwhile, the mensuration of compound protein combination rate is one of very important content in screening compound and clinical evaluation of new drug, Its substantial connection is to the pharmacological action intensity of compound.If the protein binding rate of compound is higher, long half time in blood And few side effects;If the protein binding rate of compound is low, half-life short internal elimination in blood is fast, and effect is held time Short.The assay method of common compounds protein binding rate has equilibrium dialysis, ultrafiltration, microdialysis, affinity chromatography, efficiently Molecular exclusion chromatography, high performance capillary electrophoresis, spectrographic method, nuclear magnetic resonance method, mass spectrography, Solid-phase Microextraction and doughnut Film liquid-phase micro-extraction method etc..These compound protein combine assay method and are respectively arranged with pluses and minuses, wherein hollow fiber membrane liquid-phase micro extraction Method is a kind of novel, and collection is sampled, extracted and concentrate in Sample Pretreatment Technique integrally, and Preliminary Applications is in compound egg The white mensuration combined.
The seminar of Tatjana Trtic '-Petrovic in 2005 professor (T,J Determination of drug–protein binding using supported liquid membrane extraction under Equilibrium conditions.J.Chromatogr.B 814 (2), 375-384 (2005) .) use hollow fiber membrane liquid-phase micro extraction method Success measures the compound protein binding characteristics such as lignocaine, ropivacaine, prilocaine, bupivacaine.The method is simple, Quickly, inexpensively, it is the new technique measuring compound protein binding characteristic, but this technology can not directly measure in blood plasma free Compound concentration and protein binding rate.Seminar (Fu H, Guan J, the James J.Bao.A of Bao Jianmin professor in 2006 hollow fiber solvent microextraction approach to measure drug–protein binding.Anal.Sci.22(12), 1565-1569 (2006) .) use hollow-fibre membrane liquid-liquid microextraction method to measure the protein binding rate of hydrocortisone, the method is suitable for Accept phase volume in the sufficiently bulky of donor phase less, i.e. the extraction of organic facies does not affect the reversible balance that compound protein combines. And the method is relatively accurate to the measurement result of high protein combination rate compound, but the free chemical combination in blood plasma cannot be measured simultaneously Substrate concentration and log D.Therefore need one badly and can measure blood plasma middle reaches ionization compound concentration, log D and protein binding rate simultaneously, and And the volume of donor phase does not affect the technology of measurement result with the size accepting phase volume.
Summary of the invention
It is an object of the invention to overcome the deficiencies in the prior art, it is provided that free in a kind of easily operated, quick, Accurate Determining blood plasma Compound concentration and the method for log D.
Second object of the present invention is to provide a kind of method measuring compound protein combination rate.
Technical scheme is summarized as follows:
A kind of method measuring blood plasma middle reaches ionization compound concentration and log D, comprises the steps:
(1) with concentration be 0.02-0.3M, pH be the phosphate buffer solution preparation solute of 7.4 be the solution 5mL of compound and blood plasma For donor phase, the concentration of described donor middle compound mutually is 0.2-100 μ g/mL, Plasma volumes concentration is 10-50%, by donor Put into mutually in container, in 37 DEG C of water-baths, hatch 0.5-2 hour;
(2) 50-100 μ L n-octyl alcohol is injected in the hollow-fibre membrane inner chamber that one end has sealed, heats the opening of hollow-fibre membrane End seals;The phosphate buffer solution that concentration is 0.02-0.3M of 0.5mL pH=7.4 is added, by closed at both ends in bag filter Hollow-fibre membrane and bag filter put in the solution that step (1) obtains, extract and make balance in 75-300 minute;
(3) take out liquid in bag filter, analyze the concentration [D] of compound in buffer solution with HPLCd, when this concentration is equivalent to balance Blood plasma middle reaches ionization compound concentration;Take out liquid in hollow-fibre membrane, compound concentration in n-octyl alcohol when analyzing balance with HPLC [D]a, calculate the log D of compound in blood plasma;
The computational methods of log D are Formulas I:
log D = log [ D ] a [ D ] d
Formulas I.
The molecular cut off of described bag filter is 7000-10000.
The material of hollow-fibre membrane is Kynoar, politef, polypropylene or poly-carbonic acid cellulose.
Hollow-fibre membrane uses methanol ultrasonic cleaning before use, removes the impurity on hollow-fibre membrane surface, naturally dries.
A kind of method measuring compound protein combination rate, comprises the steps:
(1) with concentration be 0.02-0.3M, pH be the phosphate buffer solution preparation solute of 7.4 be the solution 5mL of compound and blood plasma For donor phase, the concentration of described donor middle compound mutually is 0.2-100 μ g/mL, Plasma volumes concentration is 10-50%, by donor Put into mutually in container, in 37 DEG C of water-baths, hatch 0.5-2 hour;
(2) 50-100 μ L n-octyl alcohol is injected in the hollow-fibre membrane inner chamber that one end has sealed, heats the opening of hollow-fibre membrane End seals;The phosphate buffer solution that concentration is 0.02-0.3M of 0.5mL pH=7.4 is added, by closed at both ends in bag filter Hollow-fibre membrane and bag filter put in the solution that step (1) obtains, extract and make balance in 75-300 minute;
(3) take out liquid in bag filter, analyze the concentration [D] of compound in buffer solution with HPLCd, when this concentration is equivalent to balance Blood plasma middle reaches ionization compound concentration;Take out liquid in hollow-fibre membrane, compound concentration in n-octyl alcohol when analyzing balance with HPLC [D]a, calculate, obtain compound protein combination rate;
The computational methods of compound protein combination rate are Formula II:
CPB % = [ DP ] [ D ] 0 × 100 % = [ D ] 0 [ V ] 0 - [ D ] d [ V ] d - [ D ] a [ V ] a [ D ] 0 [ V ] 0 × 100 %
Formula II;
Wherein CPB% is compound protein combination rate, [V]dFor donor phase during balance and overall solution volume in bag filter;[V]aFor N-octyl alcohol volume in hollow-fibre membrane during balance;[DP] is that compound protein combines concentration;[V]0For donor phase initial volume;[D]0 For donor middle compound initial concentration mutually.
The molecular cut off of described bag filter is 7000-10000.
The material of described hollow-fibre membrane is Kynoar, politef, polypropylene or poly-carbonic acid cellulose.
Hollow-fibre membrane uses methanol ultrasonic cleaning before use, removes the impurity on hollow-fibre membrane surface, naturally dries.
Advantages of the present invention:
(1) method that hollow fiber membrane liquid-phase micro extraction method and bag filter technology combine is applied simultaneously to plasma sample by the present invention first The mensuration field of middle reaches ionization compound concentration, log D and protein binding rate thereof.
(2) analyze speed biological sample amount fast, that need few, and the quick of free cpds and binding compounds in blood plasma can be realized Separate.
(3) present invention is quick, sensitive, easy and simple to handle, low cost, need not the instrument of costliness, environmental protection.
(4) be widely used, to be widely portable in the complex samples such as biological sample, environmental sample and food samples free little molecule dense Degree measures.
Accompanying drawing explanation
Fig. 1 is the installation drawing of the method use of the present invention.In figure, 1 is container;3 is hollow-fibre membrane;4 is bag filter;5 For donor phase.
Fig. 2 be donor mutually in three kinds of balance schematic diagrams.
Detailed description of the invention
The derivation of compound protein combination rate computational methods is as follows:
It is thermodynamical equilibrium that protein is combined with compound:
In above formula, [P], [D] and [DP] represents floating preteins concentration, free cpds concentration and compound protein respectively and combines concentration. Wherein equilibrium constant KPIt is:
K P = [ DP ] [ D ] [ P ]
Assume [D0] it is precursor compound concentration, according to mass conservation law:
[DP]+[D]=[D]0
The computing formula of the free cpds quality in this experiment is as follows:
[D]0[V]0=[D]d[V]d+[D]a[V]a
[D]0For donor middle compound initial concentration mutually;[V]0For donor phase initial volume;[D]dBlood plasma middle reaches ionization when being balance Compound concentration, is equivalent to during balance in bag filter compound concentration in buffer;[V]dMolten with in bag filter for donor phase during balance Liquid cumulative volume;[D]aCompound concentration in n-octyl alcohol in hollow-fibre membrane during balance;[V]aFor the most pungent in hollow-fibre membrane during balance Alcohol volume;
The protein bound method of computerized compound is obtained according to above-mentioned formula, as follows:
CPB % = [ DP ] [ D ] 0 × 100 % = [ D ] 0 [ V ] 0 - [ D ] d [ V ] d - [ D ] a [ V ] a [ D ] 0 [ V ] 0 × 100 %
In formula, CPB% is compound protein combination rate.
Compound, plasma solutions exist three kinds of balances and sees Fig. 2.
First it is balance A between conjunction type compound and free cpds, next to that free cpds is fine in donor phase and hollow Partition equilibrium B between n-octyl alcohol in dimension film, be finally donor mutually in free cpds and bag filter in flat between buffer solution Weighing apparatus C.Conjunction type compound is quickly combined/dissociates reversible dynamic equilibrium between free cpds.The micro-extraction of hollow-fibre membrane liquid phase Taking in partition equilibrium, compound is extracted in the organic facies that chemical potential is low under the driving force of chemical potential, and final compound is being given Body phase and accepting reaches chemical potential balance between phase.Bag filter buffer solution and donor mutually in compound at the driving force of concentration Under, be distributed in the bag filter that compound concentration is little buffer solution mutually from the donor that compound concentration is big, until donor mutually in In free cpds concentration and bag filter, in buffer solution, compound concentration is equal.
The preferred Kynoar of material of hollow-fibre membrane, polypropylene, experiment proves that politef or poly-carbonic acid cellulose also may be used For the present invention, hollow-fibre membrane uses methanol ultrasonic cleaning before use, to remove the impurity in hollow-fibre membrane surface and fenestra, Naturally dry.
The present invention is further illustrated with specific embodiment below in conjunction with the accompanying drawings.
Embodiment 1
Free cpds (acetaminophen) concentration, log D and compound (acetaminophen) egg in a kind of mensuration blood plasma The method of white combination rate, comprises the steps:
(1) to 4.5mL concentration be 0.1M, pH be 7.4 phosphate buffer solution in add 2.5 μ g acetaminophen and 0.5mL Ox blood plasma (Pu Zhen bio tech ltd, Shanghai), with the solute of gained 5mL as acetaminophen with the phosphoric acid of Ox blood plasma Buffer solution is donor phase 5, and the concentration of described donor middle acetaminophen mutually is 0.5 μ g/mL, Plasma volumes concentration is 10%, Donor is put into mutually in container 1, in 37 DEG C of water-baths, hatches 0.5 hour;
(2) 50 μ L n-octyl alcohols are injected in hollow-fibre membrane 3 inner chamber that one end has sealed, heat the opening of hollow-fibre membrane Seal;The phosphate buffer solution that concentration is 0.1M of 0.5mL, pH=7.4 is added, by closed at both ends in bag filter 4 Hollow fiber film and bag filter are put in the solution that step (1) obtains, and extract and make balance in 90 minutes;The molecular cut off of bag filter It is 10000;The material of hollow-fibre membrane is polypropylene;
(3) take out liquid in bag filter, extract liquid out with HPLC syringe, analyze acetaminophen in buffer solution with HPLC Concentration [D]dBeing 0.321 μ g/mL, be equivalent to dissociate in blood plasma during balance Determination of Acetaminophen;Hollow-fibre membrane is taken out, Cut one end, with liquid in HPLC syringe taking-up hollow-fibre membrane, acetparaminosalol in n-octyl alcohol when analyzing balance with HPLC Phenol concentration is 0.656 μ g/mL, with [D]aRepresent, calculate the log D of acetaminophen in blood plasma;
The computational methods of log D are:
log D = log [ D ] a [ D ] d
Formulas I,
Being computed acetaminophen log D value is 0.31, list of references value 0.34.
Calculating the protein binding rate of acetaminophen, its computational methods are:
CPB % = [ DP ] [ D ] 0 × 100 % = [ D ] 0 [ V ] 0 - [ D ] d [ V ] d - [ D ] a [ V ] a [ D ] 0 [ V ] 0 × 100 %
Formula II,
Wherein CPB% is compound (acetaminophen) protein binding rate;[V]dMolten with in bag filter for donor phase during balance Liquid cumulative volume 5.5mL;[V]aFor n-octyl alcohol volume 50 μ L in hollow-fibre membrane during balance;[V]0For donor phase initial volume 5mL; [D]0For donor middle acetaminophen initial concentration 0.5 μ g/mL mutually.
Substituting into Formula II, obtaining acetaminophen protein binding rate is 18.58%, and list of references value is 20%.
Embodiment 2
Free cpds (dexamethasone acetate) concentration, log D and compound (dexamethasone acetate) egg in a kind of mensuration blood plasma The method of white combination rate, comprises the steps:
(1) to 2.5mL concentration be 0.3M, pH be 7.4 phosphate buffer solution in add 500 μ g dexamethasone acetate and 2.5mL Ox blood plasma (Pu Zhen bio tech ltd, Shanghai), with gained 5mL solute as dexamethasone acetate and Ox blood plasma phosphoric acid delay Dissolved liquid is donor phase, and described donor middle dexamethasone acetate concentration mutually is 100 μ g/mL, Plasma volumes concentration is 50%, will Donor is put in container mutually, hatches 2 hours in 37 DEG C of water-baths;
(2) 100 μ L n-octyl alcohols are injected in the hollow-fibre membrane inner chamber that one end has sealed, heat the opening of hollow-fibre membrane Seal;The phosphate buffer solution that concentration is 0.3M of 0.5mL pH=7.4 is added, by closed at both ends in bag filter 4 Hollow fiber film and bag filter are put in the solution that step (1) obtains, and extract and make balance in 300 minutes;The molecular cut off of bag filter It is 7000;The material of hollow-fibre membrane is politef;
(3) take out liquid in bag filter, extract liquid out with HPLC syringe, analyze dexamethasone acetate in buffer solution with HPLC Concentration [D]dBeing 7.9 μ g/mL, be equivalent to dissociate in blood plasma during balance dexamethasone acetate concentration;Hollow-fibre membrane is taken out, cuts One end, with liquid in HPLC syringe taking-up hollow-fibre membrane, dexamethasone acetate in n-octyl alcohol when analyzing balance with HPLC Concentration is 558.3 μ g/mL, with [D]aRepresent, calculate the log D of dexamethasone acetate in blood plasma by Formulas I;Dexamethasone acetate Log D value is 1.80, list of references value 1.83.
Dexamethasone acetate protein binding rate, [V] is calculated by Formula IIdFor donor phase during balance and overall solution volume 5.5 in bag filter mL;[V]aFor n-octyl alcohol volume 100 μ L in hollow-fibre membrane during balance;[V]0For donor phase initial volume 5mL;[D]0For giving Body middle dexamethasone acetate initial concentration 100 μ g/mL mutually.
Substituting into Formula II, obtaining dexamethasone acetate protein binding rate is 79.04%, and list of references value is 75%.
Embodiment 3
Free cpds (hydrocortisone) concentration, log D and compound (hydrocortisone) albumen knot in a kind of mensuration blood plasma The method of conjunction rate, comprises the steps:
(1) to 4.5mL concentration be 0.02M, pH value be 7.4 phosphate buffer solution in add 2.5 μ g hydrocortisone and 0.5mL Ox blood plasma (Pu Zhen bio tech ltd, Shanghai), with the solute of gained 5mL as hydrocortisone with the solution of Ox blood plasma is Donor phase, described donor middle hydrocortisone concentration mutually is 0.5 μ g/mL, Plasma volumes concentration is 10%, and donor is put into appearance mutually In device, in 37 DEG C of water-baths, hatch 1 hour;
(2) being injected in the hollow-fibre membrane inner chamber that one end has sealed by 50 μ L n-octyl alcohols, heating is by close for the opening of hollow-fibre membrane Envelope;The phosphate buffer solution that concentration is 0.02M of 0.5mL, pH=7.4 is added, by closed at both ends in bag filter 4 Hollow fiber film and bag filter are put in the solution that step (1) obtains, and extract and make balance in 75 minutes;The molecular cut off of bag filter It is 7000;The material of hollow-fibre membrane is Kynoar;
(3) take out liquid in bag filter, extract liquid out with HPLC syringe, analyze hydrocortisone in buffer solution with HPLC dense Degree [D]dBeing 0.023 μ g/mL, be equivalent to dissociate in blood plasma during balance hydrocortisone concentration;Hollow-fibre membrane is taken out, cuts one End, by liquid in HPLC syringe taking-up hollow-fibre membrane, hydrocortisone concentration in n-octyl alcohol when analyzing balance with HPLC It is 29.560 μ g/mL, with [D]aRepresent, calculate the log D of donor middle hydrocortisone mutually by Formulas I;Calculate hydrocortisone Log D value is 3.11, list of references value 3.11.
Hydrocortisone protein binding rate, [V] is calculated by Formula IIdFor donor phase during balance and overall solution volume 5.5mL in bag filter; [V]aFor n-octyl alcohol volume 50 μ L in hollow-fibre membrane during balance;[V]0For donor phase initial volume 5mL;[D]0For donor phase Middle hydrocortisone initial concentration 0.5 μ g/mL.
Substituting into Formula II, obtaining hydrocortisone protein binding rate is 93.01%, and list of references value is 95%.
It is demonstrated experimentally that substitute the Kynoar of the present embodiment with poly-carbonic acid cellulose, other same the present embodiment, its result and basis Embodiment is similar.
Embodiment 4
The precision of the inventive method is investigated: with hydrocortisone for test compound, this method is carried out precision investigation.
The method of embodiment 3, measures under 40 μ g/mL, 6 μ g/mL, tri-concentration of 0.2 μ g/mL in bag filter and hollow every day The concentration of hydrocortisone in n-octyl alcohol in fibrous membrane, the 5 groups of parallel laboratory tests of each concentration, calculate the log D value of hydrocortisone And protein binding rate, METHOD FOR CONTINUOUS DETERMINATION three days, the day to day precision (RSD%) of log D value is respectively 4.42%, 4.56% and 3.18%, The day to day precision (RSD%) of protein binding rate is respectively 9.29%, 8.93% and 9.67%, and the difference between parallel group is less.
By above method the result it can be seen that the mensuration compound log D that sets up of the present invention and protein binding rate method Result is relatively stable.

Claims (3)

1. measure blood plasma middle reaches ionization compound concentration, log D and a method for compound protein combination rate simultaneously, it is characterized in that including Following steps:
(1) with concentration be 0.02-0.3M, pH be the phosphate buffer solution preparation solute of 7.4 be the solution 5mL of compound and blood plasma For donor phase, the concentration of described donor middle compound mutually is 0.2-100 μ g/mL, Plasma volumes concentration is 10-50%, by donor Put into mutually in container, in 37 DEG C of water-baths, hatch 0.5-2 hour;
(2) 50-100 μ L n-octyl alcohol is injected in the hollow-fibre membrane inner chamber that one end has sealed, heats the opening of hollow-fibre membrane End seals;The phosphate buffer solution that concentration is 0.02-0.3M of 0.5mL pH=7.4 is added, by closed at both ends in bag filter Hollow-fibre membrane and bag filter put in the solution that step (1) obtains, extract and make balance in 75-300 minute;
(3) take out liquid in bag filter, analyze the concentration [D] of compound in buffer solution with HPLCd, when this concentration is equivalent to balance Blood plasma middle reaches ionization compound concentration;Take out liquid in hollow-fibre membrane, compound concentration in n-octyl alcohol when analyzing balance with HPLC [D]a, calculate log D and the compound protein combination rate of compound in blood plasma;
The computational methods of log D are Formulas I:
log D = l o g [ D ] a [ D ] d
Formulas I;
The computational methods of compound protein combination rate are Formula II:
C P B % = [ D P ] [ D ] 0 × 100 % = [ D ] 0 [ V ] 0 - [ D ] d [ V ] d - [ D ] a [ V ] a [ D ] 0 [ V ] 0 × 100 %
Formula II;
Wherein CPB% is compound protein combination rate, [V]dFor donor phase during balance and overall solution volume in bag filter;[V]aFor N-octyl alcohol volume in hollow-fibre membrane during balance;[DP] is that compound protein combines concentration;[V]0For donor phase initial volume;[D]0 For donor middle compound initial concentration mutually.
Method the most according to claim 1, is characterized in that the molecular cut off of described bag filter is 7000-10000.
Method the most according to claim 1, it is characterized in that the material of described hollow-fibre membrane be Kynoar, politef, Polypropylene or poly-carbonic acid cellulose.
CN201510017619.8A 2015-01-14 2015-01-14 A kind of measure blood plasma middle reaches ionization compound concentration, logD and the method for compound protein combination rate Active CN104569206B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510017619.8A CN104569206B (en) 2015-01-14 2015-01-14 A kind of measure blood plasma middle reaches ionization compound concentration, logD and the method for compound protein combination rate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510017619.8A CN104569206B (en) 2015-01-14 2015-01-14 A kind of measure blood plasma middle reaches ionization compound concentration, logD and the method for compound protein combination rate

Publications (2)

Publication Number Publication Date
CN104569206A CN104569206A (en) 2015-04-29
CN104569206B true CN104569206B (en) 2016-08-24

Family

ID=53085767

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510017619.8A Active CN104569206B (en) 2015-01-14 2015-01-14 A kind of measure blood plasma middle reaches ionization compound concentration, logD and the method for compound protein combination rate

Country Status (1)

Country Link
CN (1) CN104569206B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108508102A (en) * 2018-02-05 2018-09-07 贵州医科大学 The assay method of nine kinds of effect components plasma protein binding rates in Sheepear Inula Herb extract

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102565414A (en) * 2010-12-13 2012-07-11 天津市新药安全评价研究中心 Method for determining combination of polypeptide drug and plasma protein
CN103512961A (en) * 2013-09-12 2014-01-15 深圳职业技术学院 Method for determining free analyte in biological sample and determining drug protein binding ratio
CN103995037A (en) * 2014-05-28 2014-08-20 天津大学 Method for determining binding constants of echinocandins medicine and protein

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004303186A (en) * 2003-03-20 2004-10-28 Sumitomo Pharmaceut Co Ltd Device concerning prediction of protein bonding rate, and its method

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102565414A (en) * 2010-12-13 2012-07-11 天津市新药安全评价研究中心 Method for determining combination of polypeptide drug and plasma protein
CN103512961A (en) * 2013-09-12 2014-01-15 深圳职业技术学院 Method for determining free analyte in biological sample and determining drug protein binding ratio
CN103995037A (en) * 2014-05-28 2014-08-20 天津大学 Method for determining binding constants of echinocandins medicine and protein

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
A Hollow Fiber Solvent Microextraction Approach to Measure Drug–Protein Binding;Huafeng FU等;《ANALYTICAL SCIENCES DECEMBER》;20061231;第22卷;第1565-1569页 *
Equilibrium sampling through membrane based on a single hollow fibre for determination of drug–protein binding and free drug concentration in plasma;Tatjana Trtic´-Petrovic´等;《Journal of Chromatography B》;20051231;第826卷;全文 *

Also Published As

Publication number Publication date
CN104569206A (en) 2015-04-29

Similar Documents

Publication Publication Date Title
Noda Frontiers of two-dimensional correlation spectroscopy. Part 1. New concepts and noteworthy developments
Ammann et al. Intracellular neutral carrier-based Ca 2+ microelectrode with subnanomolar detection limit
Tůma et al. Determination of the spectrum of low molecular mass organic acids in urine by capillary electrophoresis with contactless conductivity and ultraviolet photometric detection—An efficient tool for monitoring of inborn metabolic disorders
Musteata et al. Bioanalytical applications of solid-phase microextraction
Thormann et al. Analysis of barbiturates in human serum and urine by high-performance capillary electrophoresis—micellar electrokinetic capillary chromatography with on-column multi-wavelength detection
Zinellu et al. N‐Methyl‐D‐glucamine improves the laser‐induced fluorescence capillary electrophoresis performance in the total plasma thiols measurement
Kubáň et al. Direct analysis of formate in human plasma, serum and whole blood by in-line coupling of microdialysis to capillary electrophoresis for rapid diagnosis of methanol poisoning
Kamps et al. Utilization of the Westöö procedure for the determination of methyl mercury in fish by gas-liquid chromatography
Liotta et al. Rapid and direct determination of creatinine in urine using capillary zone electrophoresis
Jalili et al. Bioanalytical applications of microextraction techniques: a review of reviews
CN103743843A (en) Method for detecting chloroacetic acid in air in workplace
Chen et al. Separation and determination of clenbuterol, cimaterol and salbutamol by capillary electrophoresis with amperometric detection
Das et al. Carbon-13 nuclear magnetic resonance analysis of formaldehyde free preservatives
CN102680601B (en) High-performance liquid chromatography method for measuring nucleotide in milk powder
CN104569206B (en) A kind of measure blood plasma middle reaches ionization compound concentration, logD and the method for compound protein combination rate
CN105181686B (en) The method for detecting fluorine ion in environment
CN104535548B (en) Method for rapidly detecting sulfonamide antibacterial medicines in milk by using in-tube solid-phase micro-extraction technology
CN101670190A (en) Liquid-phase micro-extraction technology for electric field enhanced hollow fibrous membrane and device for same
CN108593811B (en) Method for measuring contents of paraquat and diquat in biological body fluid
CN102866220B (en) Chemical derivation-based detection method for hemolymph metabolin of migratory locust
CN103512961B (en) Method for determining free analyte in biological sample and determining drug protein binding ratio
Jain et al. Microextraction Techniques in Analytical Toxicology: An Overview
He Microextraction and its application to forensic toxicology analysis
Vergani Crossover electrophoresis for the rapid detection of serum hepatitis (Australia) antigen and antibody.
Tůma The control of glucose and lactate levels in nutrient medium after cell incubation and in microdialysates of human adipose tissue by capillary electrophoresis with contactless conductivity detection

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant